AVR 6.45% $12.22 anteris technologies ltd

Ann: Admedus Releases Results of HSV-2 Phase IIa Study, page-206

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 326 Posts.
    lightbulb Created with Sketch. 35
    Mr Hexadecimal - Do you genuinely believe that all these holders of Admedus on hotcopper should dump the shares, or do you just enjoy trolling on HC?

    I read your posts but I never really understand why you stick around on this forum, you don't seem to be interested in the science, or the company... just taking shots at the people who are actually invested here and who are not.

    Obviously not everyone on this forum is not like me, but I did not invest in this company to make a quick buck, I actually would genuinely like to see the Australian biotech market grow, and especially in Western Australia which needs all the help it can get right now. It'll be a real shame if the company goes under, not for me, but for all the Australian's who are just giving it a fair go trying to change the world and make a living for their families.
 
watchlist Created with Sketch. Add AVR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.